DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+2.63%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$1.81B
AUM Growth
+$1.81B
(-30%)
Cap. Flow
-$568M
Cap. Flow
% of AUM
-31.37%
Top 10 Holdings %
Top 10 Hldgs %
42.89%
Holding
116
New
9
Increased
14
Reduced
41
Closed
26
Top Buys
| 1 |
XENT
Intersect ENT, Inc
XENT
|
$33.2M |
| 2 |
Glaukos
GKOS
|
$29.6M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$20.1M |
| 4 |
PDCO
Patterson Companies, Inc.
PDCO
|
$18.5M |
| 5 |
McKesson
MCK
|
$14.2M |
Top Sells
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$58.9M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$58M |
| 3 |
Elevance Health
ELV
|
$45.7M |
| 4 |
LOXO
Loxo Oncology, Inc
LOXO
|
$40.3M |
| 5 |
Centene
CNC
|
$38.7M |
Sector Composition
| 1 | Healthcare | 74.5% |
| 2 | Financials | 1.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVXS
1
DELISTED
AveXis, Inc. Common Stock
AVXS
| $190M | 10.12% | 2,308,130 +71,429 | +3% | +$5.87M |
|
|
HZNP
2
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $107M | 5.7% | 8,998,413 -1,946,575 | -18% | -$23.1M |
|
|
NXTM
3
DELISTED
NxStage Medical Inc.
NXTM
| $96.1M | 5.13% | 3,833,330 +89,179 | +2% | +$2.24M |
|
4
Gilead Sciences
GILD
$140B
| $66.4M | 3.54% | 938,515 -264,485 | -22% | -$18.7M |
|
5
Viatris
VTRS
$12.3B
| $53.1M | 2.83% | 1,367,119 -675,105 | -33% | -$26.2M |
|
|
MNK
6
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $52.8M | 2.82% | 1,178,605 +449,656 | +62% | +$20.1M |
|
|
7
McKesson
MCK
$85.4B
| $51.9M | 2.77% | 315,417 +86,417 | +38% | +$14.2M |
|
|
AERI
8
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $50.5M | 2.69% | 961,147 +165,404 | +21% | +$8.69M |
|
|
AVDL
9
Avadel Pharmaceuticals
AVDL
$1.43B
| $40.3M | 2.15% | 3,655,494 -417,315 | -10% | -$4.6M |
|
|
10
Glaukos
GKOS
$5.5B
| $37.1M | 1.98% | 894,551 +714,551 | +397% | +$29.6M |
|
|
GWPH
11
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $36.1M | 1.92% | 359,983 -65,562 | -15% | -$6.57M |
|
|
XENT
12
DELISTED
Intersect ENT, Inc
XENT
| $33.2M | 1.77% | +1,189,577 | New | +$33.2M |
|
|
BOLD
13
DELISTED
Audentes Therapeutics, Inc
BOLD
| $33.1M | 1.76% | 1,729,268 +325,615 | +23% | +$6.23M |
|
|
LCI
14
DELISTED
Lannett Company, Inc.
LCI
| $31.1M | 1.66% | 1,523,957 -329,939 | -18% | -$6.73M |
|
15
Editas Medicine
EDIT
$231M
| $28.7M | 1.53% | 1,709,400 | – | – |
|
|
NVRO
16
DELISTED
NEVRO CORP.
NVRO
| $28M | 1.49% | 376,308 -26,690 | -7% | -$1.99M |
|
|
DBVT
17
DBV Technologies
DBVT
$264M
| $23.8M | 1.27% | 665,197 -1,078,032 | -62% | -$38.5M |
|
|
PTLA
18
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $23.5M | 1.26% | 419,000 -1,032,301 | -71% | -$58M |
|
19
Cartesian Therapeutics
RNAC
$261M
| $21.1M | 1.12% | 1,060,000 | – | – |
|
|
SYRS
20
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $20.4M | 1.09% | 1,268,945 -346,191 | -21% | -$5.57M |
|
|
LOXO
21
DELISTED
Loxo Oncology, Inc
LOXO
| $20.1M | 1.07% | 251,167 -502,133 | -67% | -$40.3M |
|
|
AET
22
DELISTED
Aetna Inc
AET
| $19.7M | 1.05% | 130,000 -137,000 | -51% | -$20.8M |
|
23
BioCryst Pharmaceuticals
BCRX
$1.74B
| $19.5M | 1.04% | 3,499,202 +413,966 | +13% | +$2.3M |
|
|
PDCO
24
DELISTED
Patterson Companies, Inc.
PDCO
| $18.5M | 0.98% | +393,262 | New | +$18.5M |
|
25
DexCom
DXCM
$29.5B
| $18.1M | 0.97% | 247,841 +136,849 | +123% | +$10M |
|